Wang Y, Ren J, Hou G, Ge X
Heliyon. 2023; 9(1):e13018.
PMID: 36747924
PMC: 9898645.
DOI: 10.1016/j.heliyon.2023.e13018.
Canalis E, Schilling L, Eller T, Yu J
J Endocrinol Invest. 2022; 45(8):1507-1520.
PMID: 35352320
PMC: 10024159.
DOI: 10.1007/s40618-022-01781-y.
Frappaolo A, Karimpour-Ghahnavieh A, Sechi S, Giansanti M
Cells. 2020; 9(12).
PMID: 33321764
PMC: 7764369.
DOI: 10.3390/cells9122652.
Pacifici M
Expert Opin Orphan Drugs. 2019; 6(6):385-391.
PMID: 31448184
PMC: 6707746.
DOI: 10.1080/21678707.2018.1483232.
Ge X, Tsang K, He L, Garcia R, Ermann J, Mizoguchi F
JCI Insight. 2016; 1(4):e86254.
PMID: 27158674
PMC: 4855520.
DOI: 10.1172/jci.insight.86254.
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago A, Chmielecki J, Rosenberg M, OConnor R, Byrne C, Wilder F
Genes Chromosomes Cancer. 2015; 54(10):606-15.
PMID: 26171757
PMC: 4548882.
DOI: 10.1002/gcc.22272.
Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.
Panagopoulos I, Bjerkehagen B, Gorunova L, Taksdal I, Heim S
Oncol Rep. 2015; 34(2):577-84.
PMID: 26043835
PMC: 4487666.
DOI: 10.3892/or.2015.4035.
A broad spectrum of genomic changes in latinamerican patients with EXT1/EXT2-CDG.
Delgado M, Martinez-Domenech G, Sarrion P, Urreizti R, Zecchini L, Robledo H
Sci Rep. 2014; 4:6407.
PMID: 25230886
PMC: 4166712.
DOI: 10.1038/srep06407.
From an orphan disease to a generalized molecular mechanism: PTPN11 loss-of-function mutations in the pathogenesis of metachondromatosis.
Yang W, Neel B
Rare Dis. 2014; 1:e26657.
PMID: 25003010
PMC: 3927490.
DOI: 10.4161/rdis.26657.
Genetic alterations in chondrosarcomas - keys to targeted therapies?.
Samuel A, Costa J, Lindskog D
Cell Oncol (Dordr). 2014; 37(2):95-105.
PMID: 24458248
DOI: 10.1007/s13402-014-0166-8.
[Osteochondroma and multiple osteochondromas: recommendations on the diagnostics and follow-up with special consideration to the occurrence of secondary chondrosarcoma].
Herget G, Kontny U, Saueressig U, Baumhoer D, Hauschild O, Elger T
Radiologe. 2013; 53(12):1125-36.
PMID: 24129968
DOI: 10.1007/s00117-013-2571-9.
Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome.
Pansuriya T, van Eijk R, dAdamo P, van Ruler M, Kuijjer M, Oosting J
Nat Genet. 2011; 43(12):1256-61.
PMID: 22057234
PMC: 3427908.
DOI: 10.1038/ng.1004.
Chondrosarcoma: with updates on molecular genetics.
Kim M, Cho K, Ayala A, Ro J
Sarcoma. 2011; 2011:405437.
PMID: 21403832
PMC: 3042668.
DOI: 10.1155/2011/405437.
A"Proteoglycan targeting strategy" for the scintigraphic imaging and monitoring of the swarm rat chondrosarcoma orthotopic model.
Peyrode C, Gouin F, Vidal A, Auzeloux P, Besse S, Dauplat M
Sarcoma. 2011; 2011:691608.
PMID: 21331335
PMC: 3038667.
DOI: 10.1155/2011/691608.
Cartilage tumours and bone development: molecular pathology and possible therapeutic targets.
Bovee J, Hogendoorn P, Wunder J, Alman B
Nat Rev Cancer. 2010; 10(7):481-8.
PMID: 20535132
DOI: 10.1038/nrc2869.